Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

APOTIKEREZH : revenue, balance sheet and financial ratios

APOTIKEREZH is a French company founded 17 years ago, specialized in the sector Gestion de fonds. Based in CARHAIX-PLOUGUER (29270), this company of category PME shows in 2016 a revenue of 1.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - APOTIKEREZH (SIREN 507511228)
Indicator 2018 2017 2016
Revenue N/C N/C 1 949 067 €
Net income 93 331 € 110 277 € 91 751 €
EBITDA N/C N/C 123 190 €
Net margin N/C N/C 4.7%

Revenue and income statement

In 2018, APOTIKEREZH generates positive net income of 93 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2018: 92 k€ -> 93 k€.

Net income (2018) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

93 331 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 23%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 72%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2018) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

23.214%

Financial autonomy (2018) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

71.834%

Asset age ratio (2018) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

14.0%

Solvency indicators evolution
APOTIKEREZH

Sector positioning

Debt ratio
23.21 2018
2016
2017
2018
Q1: 0.02
Med: 13.47
Q3: 95.23
Average -14 pts over 3 years

In 2018, the debt ratio of APOTIKEREZH (23.21) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
71.83% 2018
2016
2017
2018
Q1: 16.16%
Med: 54.74%
Q3: 86.93%
Good +13 pts over 3 years

In 2018, the financial autonomy of APOTIKEREZH (71.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
6.06 years 2016
2016
Q1: 0.0 years
Med: 0.03 years
Q3: 3.27 years
Average

In 2016, the repayment capacity of APOTIKEREZH (6.06) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 197.21. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2018) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

197.213

Liquidity indicators evolution
APOTIKEREZH

Sector positioning

Liquidity ratio
197.21 2018
2016
2017
2018
Q1: 110.43
Med: 366.1
Q3: 1997.4
Average

In 2018, the liquidity ratio of APOTIKEREZH (197.21) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
8.85x 2016
2016
Q1: -33.21x
Med: 0.0x
Q3: 1.8x
Excellent

In 2016, the interest coverage of APOTIKEREZH (8.8x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2018) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2018) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2018) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2018) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
APOTIKEREZH

Positioning of APOTIKEREZH in its sector

Comparison with sector Gestion de fonds

Valuation estimate

Based on 70 transactions of similar company sales in 2018, the value of APOTIKEREZH is estimated at 761 594 € (range 351 957€ - 1 522 070€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2018
70 tx
351k€ 761k€ 1522k€
761 594 € Range: 351 957€ - 1 522 070€
NAF 5 année 2018

Valuation method used

Net Income Multiple
93 331 € × 8.2x = 761 594 €
Range: 351 958€ - 1 522 070€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 70 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Gestion de fonds)

Compare APOTIKEREZH with other companies in the same sector:

Frequently asked questions about APOTIKEREZH

What is the revenue of APOTIKEREZH ?

The revenue of APOTIKEREZH in 2016 is 1.9 M€.

Is APOTIKEREZH profitable?

Yes, APOTIKEREZH generated a net profit of 93 k€ in 2018.

Where is the headquarters of APOTIKEREZH ?

The headquarters of APOTIKEREZH is located in CARHAIX-PLOUGUER (29270), in the department Finistere.

Where to find the tax return of APOTIKEREZH ?

The tax return of APOTIKEREZH is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does APOTIKEREZH operate?

APOTIKEREZH operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.